Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.
about
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@en
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@nl
type
label
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@en
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@nl
prefLabel
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@en
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@nl
P2093
P2860
P356
P1433
P1476
Pyrimidine metabolic rate limi ...... ssociated with poor prognosis.
@en
P2093
Chieh-Yu Chang
Chun-Mei Hu
Hsi-Wen Yeh
Szu-Shuo Lee
Yuh-Shan Jou
P2860
P304
77734-77751
P356
10.18632/ONCOTARGET.20774
P407
P577
2017-09-08T00:00:00Z